Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$12.75−0.40 (-3.04%)
Close on Nov 16, 2026Market cap $86.56MP/E –Yield –
Eloxx Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Eloxx Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2012 was -2705.8%. For fiscal 2024 it was -38.8%, against -5019.9% the year before. The highest annual figure on record is -38.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -38.8% | +4981.1 |
| FY2014 | Jun 30, 2014 | -5019.9% | +54457.0 |
| FY2013 | Jun 30, 2013 | -59476.9% | −56771.2 |
| FY2012 | Jun 30, 2012 | -2705.8% | +756.0 |
| FY2010 | Jun 30, 2010 | -3461.8% | – |
See a number that looks wrong?